IPO Update: Codiak BioSciences Proposes IPO Terms

Codiak BioSciences has filed to raise $82.5 million in an IPO.

The firm is advancing a pipeline of exosome-based treatment candidates for cancer and other diseases.

CDAK has developed significant collaboration partnerships with major pharma firms and the IPO appears priced within the typical range for biopharma companies.